Literature DB >> 11590841

Risk factors for pulmonary arterial hypertension.

M Humbert1, H Nunes, O Sitbon, F Parent, P Hervé, G Simonneau.   

Abstract

The present limitations in knowledge of the potential risk factors for PPH undoubtedly are attributable to the facts that PPH is a rare disease with an unknown pathogenesis and lacking large case series. Moreover, definite epidemiologic data are rare and ideally should be obtained from epidemiologic surveys such as large case-control studies. The increased incidence of the disease in young women, the familial cases, the association with autoimmune disorders, and the recent discovery that mutation of the PPH1 gene may not be restricted to familial PPH support the hypothesis that the development of pulmonary hypertension likely implies an individual susceptibility or predisposition, which is probably genetically determined. It is also now commonly believed that the development of pulmonary hypertension in some of these predisposed individuals could be hastened or precipitated by various expression factors (some of them yet unrecognized), such as ingestion of certain drugs or diets, portal hypertension, or HIV infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590841     DOI: 10.1016/s0272-5231(05)70284-7

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  18 in total

1.  Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure.

Authors:  R J Barst; L Abenhaim
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 2.  Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

Authors:  Marjorie Barrier; Jolyane Meloche; Maria Helena Jacob; Audrey Courboulin; Steeve Provencher; Sébastien Bonnet
Journal:  Cell Mol Life Sci       Date:  2012-03-25       Impact factor: 9.261

Review 3.  CT imaging of peripheral pulmonary vessel disease.

Authors:  Arnaud Resten; Sophie Maitre; Dominique Musset
Journal:  Eur Radiol       Date:  2005-05-20       Impact factor: 5.315

Review 4.  Pulmonary hypertension-"state of the art" management in 2012.

Authors:  Anita Saxena
Journal:  Indian Heart J       Date:  2012-03-26

5.  What patients and their relatives think about testing for BMPR2.

Authors:  Diana L Jones; Joanne C Sandberg; Mary J Rosenthal; Robert C Saunders; Vickie L Hannig; Ellen W Clayton
Journal:  J Genet Couns       Date:  2008-09-13       Impact factor: 2.537

6.  Pulmonary hypertension.

Authors:  John H Newman
Journal:  Am J Respir Crit Care Med       Date:  2005-06-30       Impact factor: 21.405

7.  Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis.

Authors:  Walter Serra; Alfredo Chetta; Daniele Santilli; Flavio Mozzani; Pier Paolo Dall'Aglio; Dario Olivieri; Maria Alberta Cattabiani; Diego Ardissino; Tiziano Gherli
Journal:  Cardiovasc Ultrasound       Date:  2010-07-05       Impact factor: 2.062

Review 8.  Genetics and mediators in pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd
Journal:  Clin Chest Med       Date:  2007-03       Impact factor: 2.878

9.  Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice.

Authors:  Eri Ochiai; Katsuhiko Kamei; Akira Watanabe; Masaru Nagayoshi; Yuji Tada; Tetsutaro Nagaoka; Koichi Sato; Ayaka Sato; Kazutoshi Shibuya
Journal:  Int J Exp Pathol       Date:  2008-06       Impact factor: 1.925

Review 10.  Etiology, diagnosis, and pharmacologic treatment of pediatric pulmonary hypertension.

Authors:  Robert Tulloh
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.